A Phase II/III Randomized Study Comparing Efficacy of Nolatrexed (Thymitaq, AG337) to Doxorubicin in Patients with Unresectable Hepatocellular Carcinoma (HCC)
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListMok, T., M. Liu, S. Lee, Y Chao, T Leung, A. Johnston, P. Johnson
Name of ConferenceProceedings of the 10th Nci-Eortc Symposium on New Drugs in Cancer Therapy
Start Date of Conference18/06/1999
Proceedings TitleProceedings of the 10th Nci-Eortc Symposium on New Drugs in Cancer Therapy
Year1999
Month6
Day18
PublisherNci-Eortc
LanguagesEnglish-United Kingdom
KeywordsHEPATOMA ; NOLATREXED ; RANDOMIZED STUDY

Last updated on 2018-18-01 at 20:23